Trinity Biotech PLC (TRIB)
1.22
-0.08
(-6.15%)
USD |
NASDAQ |
Nov 22, 12:32
Trinity Biotech Total Assets (Quarterly): 97.45M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 97.45M |
| June 30, 2024 | 94.36M |
| March 31, 2024 | 90.30M |
| December 31, 2023 | 59.44M |
| September 30, 2023 | 63.60M |
| June 30, 2023 | 71.99M |
| March 31, 2023 | 91.16M |
| December 31, 2022 | 92.10M |
| September 30, 2022 | 97.90M |
| June 30, 2022 | 107.14M |
| March 31, 2022 | 106.10M |
| December 31, 2021 | 118.90M |
| September 30, 2021 | 122.78M |
| June 30, 2021 | 124.72M |
| March 31, 2021 | 135.98M |
| December 31, 2020 | 130.40M |
| September 30, 2020 | 136.08M |
| June 30, 2020 | 128.73M |
| March 31, 2020 | 129.13M |
| December 31, 2019 | 131.07M |
| September 30, 2019 | 173.25M |
| June 30, 2019 | 171.70M |
| March 31, 2019 | 172.65M |
| December 31, 2018 | 151.66M |
| September 30, 2018 | 183.33M |
| Date | Value |
|---|---|
| June 30, 2018 | 194.45M |
| March 31, 2018 | 194.68M |
| December 31, 2017 | 192.97M |
| September 30, 2017 | 244.62M |
| June 30, 2017 | 244.80M |
| March 31, 2017 | 245.14M |
| December 31, 2016 | 249.59M |
| September 30, 2016 | 360.47M |
| June 30, 2016 | 357.77M |
| March 31, 2016 | 360.04M |
| December 31, 2015 | 363.68M |
| September 30, 2015 | 355.38M |
| June 30, 2015 | 359.76M |
| March 31, 2015 | 246.78M |
| December 31, 2014 | 242.84M |
| September 30, 2014 | 237.00M |
| June 30, 2014 | 238.45M |
| March 31, 2014 | 228.92M |
| December 31, 2013 | 226.49M |
| September 30, 2013 | 222.88M |
| June 30, 2013 | 203.44M |
| March 31, 2013 | 203.38M |
| December 31, 2012 | 197.41M |
| September 30, 2012 | 189.91M |
| June 30, 2012 | 183.95M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
59.44M
Minimum
Dec 2023
136.08M
Maximum
Sep 2020
106.46M
Average
106.62M
Median
Total Assets (Quarterly) Benchmarks
| Amarin Corp PLC | 750.62M |
| DBV Technologies SA | 93.06M |
| Ascendis Pharma AS | 1.222B |
| Cellectis SA | 395.88M |
| Adaptimmune Therapeutics PLC | 317.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 123.79M |
| Shareholders Equity (Quarterly) | -26.34M |
| Debt to Equity Ratio | -3.106 |
| Current Ratio | 1.642 |
| Net Debt Paydown Yield | -53.20% |